Lucintel Forecasts The Global Transcatheter Mitral Valve Replacement Market To Grow With A Cagr Of 15.7% From 2025 To 2031

By Author: Lucintel LLC
Total Articles: 7757
Comment this article

According to a market report by Lucintel, the future of the global transcatheter mitral valve replacement market looks promising with opportunities in the functional mitral regurgitation and degenerative mitral regurgitation markets. The global transcatheter mitral valve replacement market is expected to grow with a CAGR of 15.7% from 2025 to 2031. The major drivers for this market are the increasing prevalence of mitral valve regurgitation, the rising adoption of minimally invasive cardiac procedures, and the growing geriatric population with cardiac disorders.
A more than 150-page report to understand trends, opportunity and forecast in global transcatheter mitral valve replacement market to 2031 by type (MitraClip, edwards PASCAL, and edwards SAPIEN 3), application (functional mitral regurgitation and degenerative mitral regurgitation), and region (North America, Europe, Asia Pacific, and the Rest of the World).
Lucintel forecasts that, within the type category, MitraClip is expected to witness higher growth over the forecast period.
Within the application category, functional mitral regurgitation is expected ...
... to witness the highest growth.
Download sample by clicking on transcatheter mitral valve replacement market.
In terms of region, APAC is expected to witness the highest growth over the forecast period.
Abbott, Edwards Lifesciences, Medtronic, Boston Scientific, Micro Interventional Devices, Neovasc, Zhenyi Medical are the major suppliers in the transcatheter mitral valve replacement market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com. To get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
Local Anesthetic Cream Market
Hazardous Drug Closed System Transfer Device Market
Hybridoma Technology Market
Goat Polyclonal Antibody Market
Dural Patch Market